Research Article
[Retracted] Overexpression of 14-3-3δ Predicts Poor Prognosis in Extrahepatic Cholangiocarcinoma Patients
Table 3
Univariate and multivariate analyses of overall survival in 65 extrahepatic cholangiocarcinoma patients.
| | | Multivariate | | Univariate value | value | Relative risk (95% CI) |
| | Gender | 0.245 | None | None | | Age | 0.606 | None | None | | Tumor size | 0.0973 | None | None | | Pathologic differentiation1 | 0.043 | 0.087 | 2.13 (0.968–9.043) | | Lymphatic permeation1 | 0.003 | 0.066 | 4.77 (0.743–15.814) | | Tumor stage1 | 0.009 | 0.02 | 3.13 (1.352–10.241) | | 14-3-3δ level1 | 0.002 | 0.035 | 10.23 (2.516–95.568) |
|
|
1Data were considered significant by univariate analyses and examined by multivariate analyses.
|